Nomax, INC FDA Inspection Record
Nomax, INC is an FDA-registered facility (FEI 1937310) located in Affton, MO, US. Registered operations: MANUFACTURE. RegDataLab tracks 10 FDA inspections and 1 compliance action at this facility.
What FDA found at this site
- Latest inspection
- Feb 25, 2026: No Action Indicated (NAI)
- Inspections on record
- 10 (1 OAI, 5 VAI, 4 NAI)
- Last OAI inspection
- Oct 27, 2016
- Warning letters
- 1 listed by FDA for this FEI, latest Dec 15, 2016
- Recalls as the recalling firm
- 3, latest Apr 19, 2024
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Feb 25, 2026 | No Action Indicated (NAI) | No citations listed |
| Feb 16, 2024 | No Action Indicated (NAI) | No citations listed |
| Dec 2, 2022 | Voluntary Action Indicated (VAI) | No citations listed |
| Jun 24, 2022 | No Action Indicated (NAI) | No citations listed |
| Feb 1, 2018 | Voluntary Action Indicated (VAI) | No citations listed |
| Oct 27, 2016 | Official Action Indicated (OAI) | DHR - not or inadequately maintained (21 CFR 820.184) Documentation (21 CFR 820.80(e)) Nonconforming product control (21 CFR 820.90(a)) Investigation of device failures (21 CFR 820.198(c)) and 3 more |
| Sep 17, 2014 | Voluntary Action Indicated (VAI) | Lack of or inadequate complaint procedures (21 CFR 820.198(a)) Acceptable supplier records, inadequate records (21 CFR 820.50(a)(3)) Training - Lack of or inadequate procedures (21 CFR 820.25(b)) Lack of or inadequate procedures - Acceptance activities (21 CFR 820.80(a)) and 14 more |
| Jan 31, 2012 | Voluntary Action Indicated (VAI) | SOPs not followed / documented (21 CFR 211.100(b)) Absence of Written Procedures (21 CFR 211.100(a)) Control procedures to monitor and validate performance (21 CFR 211.110(a)) Establishment of calibration procedures (21 CFR 211.160(b)(4)) and 5 more |
| Mar 25, 2011 | Voluntary Action Indicated (VAI) | GMP Training Frequency (21 CFR 211.25(a)) Written program not followed (21 CFR 211.166(a)) |
| Jul 26, 2010 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Apr 19, 2024 | Class II | D-0462-2024 | GloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100… and 3 more products Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to… |
| Apr 13, 2021 | Class III | D-0387-2021 | Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100… Subpotent Drug |
| Mar 24, 2015 | Class III | D-0961-2015 | Fluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Fluorescein… and 2 more products Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of… |
FDA record score
15 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
8 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Warning letter on FDA's dashboard, which does not show close-outs | Dec 15, 2016 | 30 x 0.25 | 7.5 |
| Inspection classified VAI | Dec 2, 2022 | 6 x 0.6 | 3.6 |
| Class II recall D-0462-2024, this FEI as the recalling firm | Apr 19, 2024 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Feb 1, 2018 | 6 x 0.25 | 1.5 |
| Inspection classified OAI | Oct 27, 2016 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 17, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jan 31, 2012 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Mar 25, 2011 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Nomax, INC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Nomax, INC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Nomax, Inc.
- Location
- Affton, MO (US)
- Registration Expires
- Dec 31, 2026
- Operations
- MANUFACTURE
- Source
- both